Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Liabilities and Shareholders Equity (2021 - 2025)

Tenon Medical (TNON) has 5 years of Liabilities and Shareholders Equity data on record, last reported at $10.4 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 20.5% year-over-year to $10.4 million; the TTM value through Sep 2025 reached $44.7 million, up 33.84%, while the annual FY2024 figure was $9.8 million, 55.13% up from the prior year.
  • Liabilities and Shareholders Equity reached $10.4 million in Q3 2025 per TNON's latest filing, down from $11.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $18.1 million in Q2 2022 and bottomed at $6.0 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $10.2 million, with a median of $9.8 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: plummeted 51.01% in 2023, then surged 85.05% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $9.3 million in 2021, then grew by 19.6% to $11.1 million in 2022, then tumbled by 42.78% to $6.3 million in 2023, then skyrocketed by 55.13% to $9.8 million in 2024, then grew by 5.31% to $10.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $10.4 million in Q3 2025, $11.1 million in Q2 2025, and $13.4 million in Q1 2025.